Scarica l'app Stockscreener
8.12
3.18%
0.25
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AVTR Giù?
Forum
Previsione
Precedente Chiudi:
$7.87
Aprire:
$7.84
Volume 24 ore:
7.20M
Relative Volume:
0.76
Capitalizzazione di mercato:
$5.54B
Reddito:
$6.55B
Utile/perdita netta:
$-551.40M
Rapporto P/E:
-10.05
EPS:
-0.8082
Flusso di cassa netto:
$438.90M
1 W Prestazione:
+6.56%
1M Prestazione:
-1.93%
6M Prestazione:
-29.51%
1 anno Prestazione:
-36.86%
Intervallo 1D:
$7.81
$8.13
Intervallo di 1 settimana:
$7.424
$8.13
Portata 52W:
$7.265
$15.93
Avantor Inc Stock (AVTR) Company Profile
Nome
Avantor Inc
Settore
Industria
Telefono
(610) 386-1700
Indirizzo
RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA
Compare AVTR vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVTR
Avantor Inc
|
8.12 | 5.37B | 6.55B | -551.40M | 438.90M | -0.8082 |
ISRG
Intuitive Surgical Inc
|
438.10 | 155.76B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
147.63 | 40.30B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.78 | 33.13B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
37.01 | 31.37B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
208.05 | 30.31B | 5.54B | 1.52B | 1.74B | 10.37 |
Avantor Inc Stock (AVTR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-06 | Downgrade | Barclays | Equal Weight → Underweight |
| 2026-01-05 | Downgrade | Evercore ISI | Outperform → In-line |
| 2025-12-17 | Downgrade | Jefferies | Hold → Underperform |
| 2025-12-15 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-11-04 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2025-10-30 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-10-30 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-08-01 | Downgrade | Jefferies | Buy → Hold |
| 2025-04-29 | Downgrade | Goldman | Buy → Neutral |
| 2025-04-28 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-04-28 | Downgrade | Stifel | Buy → Hold |
| 2025-04-28 | Downgrade | TD Cowen | Buy → Hold |
| 2025-01-17 | Downgrade | UBS | Buy → Neutral |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-07-10 | Downgrade | Citigroup | Buy → Neutral |
| 2024-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-12-11 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-31 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-07-31 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-06-21 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-12-14 | Iniziato | Deutsche Bank | Hold |
| 2022-10-05 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-09-14 | Downgrade | Cowen | Outperform → Market Perform |
| 2022-09-09 | Downgrade | Cleveland Research | Buy → Neutral |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-04 | Downgrade | Citigroup | Buy → Neutral |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-30 | Ripresa | Raymond James | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-08-02 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-06-04 | Iniziato | Goldman | Buy |
| 2021-04-29 | Aggiornamento | Stifel | Hold → Buy |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-08-02 | Iniziato | Cleveland Research | Neutral |
| 2019-06-14 | Iniziato | Janney | Buy |
| 2019-06-12 | Iniziato | Raymond James | Outperform |
| 2019-06-11 | Iniziato | Goldman | Buy |
| 2019-06-11 | Iniziato | Guggenheim | Buy |
| 2019-06-11 | Iniziato | JP Morgan | Overweight |
| 2019-06-11 | Iniziato | Jefferies | Buy |
| 2019-06-11 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2019-06-11 | Iniziato | Piper Jaffray | Neutral |
| 2019-06-11 | Iniziato | RBC Capital Mkts | Outperform |
| 2019-06-11 | Iniziato | Robert W. Baird | Outperform |
| 2019-06-11 | Iniziato | SunTrust | Buy |
| 2019-06-11 | Iniziato | UBS | Buy |
| 2019-06-11 | Iniziato | William Blair | Outperform |
Mostra tutto
Avantor Inc Borsa (AVTR) Ultime notizie
Understanding the Setup: (AVTR) and Scalable Risk - Stock Traders Daily
Avantor (AVTR): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman - The National Law Review
Circumference Group LLC's Avantor Inc(AVTR) Holding History - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Avantor’s SWOT analysis: life sciences stock faces mounting pressures By Investing.com - Investing.com Nigeria
Avantor appoints Gerard Porreca as quality and regulatory EVP - Investing.com UK
Avantor appoints Gerard Porreca as quality and regulatory EVP By Investing.com - Investing.com South Africa
Global Cell Culture Media Market Outlook 2026-2036: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, and Lonza Group AG - PR Newswire UK
Press Release: Avantor(R) Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory - Moomoo
Avantor’s SWOT analysis: life sciences stock faces mounting pressures - Investing.com
Avantor (AVTR) Fell as Destocking Has Lasted Longer Than Expected - Insider Monkey
Avantor (AVTR) Slid on Lower Than Expected Guidance - Insider Monkey
Avantor stock (US0543031027): focus shifts to margin recovery after Q1 earnings - AD HOC NEWS
Avantor, Inc. Common Stock (NY: AVTR - The Chronicle-Journal
Avantor's Turnaround Story Ongoing, Execution Risks Remain, RBC Says - marketscreener.com
RBC Capital assumes Avantor stock coverage with $9 target - Investing.com UK
RBC Capital assumes Avantor stock coverage with $9 target By Investing.com - Investing.com Nigeria
Avantor forecasts Q2 adjusted EPS of $0.19-$0.20 while incorporating $10M-$20M inflation headwind - MSN
Avantor Shareholders Approve Proposals at 2026 Annual Meeting - The Globe and Mail
Avantor (NYSE: AVTR) shareholders back board, pay plan and auditor in 2026 vote - Stock Titan
Avantor stock (US0543031027): Director Lucier buys $83,200 worth amid 31% yearly decline - AD HOC NEWS
Avantor director Gregory Lucier buys $83,200 in company stock - Investing.com India
Avantor director Gregory Lucier buys $83,200 in company stock By Investing.com - Investing.com Canada
Avantor (AVTR) director Mala Murthy granted 25,270 restricted stock units - Stock Titan
Avantor (NYSE: AVTR) director buys 10K shares and receives RSU grant - Stock Titan
Stock grant lifts Avantor (NYSE: AVTR) director Simon Dingemans’ holdings - Stock Titan
Avantor (AVTR) director Louise Makin receives 25,270-share restricted stock grant - Stock Titan
Avantor (AVTR) director Joseph Massaro granted 25,270 restricted stock units - Stock Titan
Avantor (AVTR) director awarded 25,270 RSUs vesting in May 2027 - Stock Titan
Avantor (AVTR) director receives 25,270-share equity grant, now holds 85,821 - Stock Titan
Avantor (AVTR) director Gregory Summe granted 25,270 RSUs, reports trust holdings - Stock Titan
The Technical Signals Behind (AVTR) That Institutions Follow - Stock Traders Daily
Flat Q1 Margins At Avantor (AVTR) Could Be A Game Changer For Its Efficiency Story - Sahm
Avantor shares jump 9% after Q1 earnings beat - MSN
Avantor expands Masterflex portfolio to streamline bioprocessing - MSN
Avantor (AVTR) Earnings Date and Reports 2026 $AVTR - MarketBeat
Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Avantor Reports Lower Q1 Profit, Reaffirms 2026 Guidance - MyChesCo
Avantor Inc Azioni (AVTR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.79%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):